Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
22m
EU regulator backs use of Novo's Wegovy for obesity related heart condition
Novo's US rival Eli Lilly's drug tirzepatide is also approved for weight loss in the EU. Tirzepatide has shown to cut heart ...
51m
Novo Nordisk's Wegovy Recommended For Label Update To Reflect Heart Failure Benefits
Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Makes MLB history
COVID, Wuhan market link
Rally attendees injured
Boy kills bear, saves father
Ban called for in TX schools
To get a second moon
Families lose appeal
To receive Holbrooke award
NYC subway joyride arrest
Gun case sentencing delay
30 yrs in prison for assault
Joins Motion Picture Assn.
Man charged for threats
EU warns Apple
160M euros to Ukraine
UN backs Palestine
Cancer deaths decline
Launches AI assistant
Existing home sales drop
Israel strikes Hezbollah
US jobless claims fall
Retaliated against scientists
Los Angeles dengue cases
FTC on privacy controls
New SEC stock pricing rule
Deal to build new arena
US healthcare system falls
AC mayor, wife indicted
Sets new WNBA record
Hails economic progress
Dow, S&P hit record highs
Related topics
Novo Nordisk
Ozempic
Amycretin
Feedback